← Leaderboards
Stephen M Ansell
Mayo Clinic Coll Of Medicine, Rochester
$7,057,055
Attributed
$7,057,055
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $827.4K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,057,055 · 7
By mechanism
P50$3,945,881 · 3
R01$1,985,235 · 1
P30$563,302 · 1
R21$562,400 · 1
M01$237 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- James R Cerhan$31,221,407
- Thomas E. Witzig$5,636,824
Others in their field
Top investigators on “Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
LymphomaMalignant NeoplasmsCellsMalignant - DescriptorCancer CellT-LymphocyteImmune ResponseMonocyteSiteTumorNon-Hodgkin&AposS LymphomaPlayLymph NodesPreventRecruitment ActivityImmunityCell GrowthImmuneB-LymphocytesAreaLeadBaseTissues
Grant awards (33)
Hematologic Malignancies Program$81,537
P30 · FY2024 · CA · contact PI
Hematologic Malignancies Program$99,154
P30 · FY2023 · CA · contact PI
Hematologic Malignancies Program$99,278
P30 · FY2022 · CA · contact PI
Hematologic Malignancies Program$99,154
P30 · FY2021 · CA · contact PI
Project 1: Activating Phagocytic Macrophages in non-Hodgkin Lymphoma$251,021
P50 · FY2020 · CA · contact PI
Hematologic Malignancies Program$101,598
P30 · FY2020 · CA · contact PI
Project 1: Activating Phagocytic Macrophages in non-Hodgkin Lymphoma$246,731
P50 · FY2019 · CA · contact PI
Hematologic Malignancies Program$82,581
P30 · FY2019 · CA · contact PI
Project 1: Activating Phagocytic Macrophages in non-Hodgkin Lymphoma$263,517
P50 · FY2018 · CA · contact PI
Project 1: Activating Phagocytic Macrophages in non-Hodgkin Lymphoma$259,996
P50 · FY2017 · CA · contact PI
The Role of Monocytes in non-Hodgkin Lymphoma$279,404
P50 · FY2016 · CA · contact PI
The Role of Monocytes in non-Hodgkin Lymphoma$275,600
P50 · FY2015 · CA · contact PI
The Role of Monocytes in non-Hodgkin Lymphoma$279,492
P50 · FY2014 · CA · contact PI
The Role of Monocytes in non-Hodgkin Lymphoma$275,668
P50 · FY2013 · CA · contact PI
The Role of Monocytes in non-Hodgkin Lymphoma$107,311
P50 · FY2013 · CA · contact PI
The Role of Monocytes in non-Hodgkin Lymphoma$296,953
P50 · FY2012 · CA · contact PI
The Role of Monocytes in non-Hodgkin Lymphoma$10,064
P50 · FY2012 · CA · contact PI
P4 - Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin$261,777
P50 · FY2011 · CA · contact PI
Biologic Therapy for B-cell non-Hodgkin's Lymphoma$250,979
R01 · FY2011 · CA · contact PI
P4 - Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin$276,045
P50 · FY2010 · CA · contact PI
Biologic Therapy for B-cell non-Hodgkin's Lymphoma$258,741
R01 · FY2010 · CA · contact PI
Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin$277,767
P50 · FY2009 · CA · contact PI
Biologic Therapy for B-cell non-Hodgkin's Lymphoma$258,741
R01 · FY2009 · CA · contact PI
Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin$287,478
P50 · FY2008 · CA · contact PI
BLys inhibition using TACI-Fc in patients with B-bell non-Hodgkins' Lymphoma$281,200
R21 · FY2008 · CA · contact PI
Biologic Therapy for B-cell non-Hodgkin's Lymphoma$258,741
R01 · FY2008 · CA · contact PI
Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin$297,057
P50 · FY2007 · CA · contact PI
BLys inhibition using TACI-Fc in patients with B-bell non-Hodgkins' Lymphoma$281,200
R21 · FY2007 · CA · contact PI
Biologic therapy for Beta-cell non-Hodgkin's lymphoma$240,231
R01 · FY2005 · CA
INTRA-TUMORAL INJECTION OF MEASLES VIRUS VACCINE IN PATIENTS WITH RELAPSED B-CEL$237
M01 · FY2005 · RR
Biologic therapy for Beta-cell non-Hodgkin's lymphoma$240,231
R01 · FY2004 · CA
Biologic therapy for Beta-cell non-Hodgkin's lymphoma$240,231
R01 · FY2003 · CA
Biologic therapy for Beta-cell non-Hodgkin's lymphoma$237,340
R01 · FY2002 · CA